{
  "trial_id": "NCT03520660",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Male or female, age greater than or equal to 18 years.",
      "label": "met"
    },
    {
      "criterion": "Either treatment na(SqrRoot) ve or experienced defined as failure of a prior course of interferon-based and ribavirin, DAA plus interferon and DAA only (except for NS5a failures).",
      "label": "met"
    },
    {
      "criterion": "Confirmation of chronic HCV infection documented by either: A positive HCV RNA or positive HCV genotyping test at least 6 months prior to the Baseline/Day 1 visit, or A liver biopsy performed prior to screening visit showing evidence of chronic hepatitis.",
      "label": "met"
    },
    {
      "criterion": "Subjects must have the following laboratory parameters at screening: ALT less than or equal to 10 (SqrRoot) the upper limit of normal (ULN)",
      "label": "met"
    },
    {
      "criterion": "AST less than or equal 10 (SqrRoot) ULN",
      "label": "met"
    },
    {
      "criterion": "Total bilirubin <2.5 mg/dL, Direct bilirubin less than or equal 1.5 ULN",
      "label": "met"
    },
    {
      "criterion": "Platelets more than or equal 50,000 K/mm3",
      "label": "met"
    },
    {
      "criterion": "HbA1c less than or equal 8.5%",
      "label": "met"
    },
    {
      "criterion": "eGFR more than or equal 60 mL /min, as calculated by the CKD-EPI equation.",
      "label": "met"
    },
    {
      "criterion": "Hemoglobin more than or equal 10g/dL",
      "label": "met"
    },
    {
      "criterion": "Albumin more than or equal 3g/dL",
      "label": "met"
    },
    {
      "criterion": "INR less than or equal 1.5 unless subject has known hemophilia or is stable on an anticoagulant regimen affecting INR.",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnancy, active breast-feeding, or inability to practice adequate contraception, in women of childbearing potential. Adequate contraception is defined as vasectomy in men, tubal ligation in women, or use of one method such as condoms and spermicide combination, birth control pills, an intrauterine device, Depo-Provera, or Norplant until 12 weeks post therapy.",
      "label": "not_met"
    },
    {
      "criterion": "Current or prior history of any of the following: Clinically-significant illness (other than HCV) or any other major medical disorder that may interfere with subject treatment, assessment or compliance with the protocol; subjects currently under evaluation for a potentially clinically-significant illness (other than HCV) are also excluded.",
      "label": "unknown"
    },
    {
      "criterion": "Gastrointestinal disorder or post-operative condition that could interfere with the absorption of the study drug.",
      "label": "not_met"
    }
  ],
  "notes": "The patient is a 53-year-old man with chronic HCV infection. He has been on IFN and RBV combination therapy for 9 months, with direct antiviral drugs added 6 months ago. His medical record shows previous positive HCV RNA tests and anti-HCV-antibodies. The recent biopsy was negative for hepatocellular carcinoma and showed chronic inflammation compatible with a chronic viral hepatitis.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT03520660",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}